Revenue: The sum of all revenue fields included for a company's operating activities.
Ginkgo Bioworks Holdings, Inc. (DNA) had Revenue of $48.32M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$48.32M |
$-90.96M |
|
$12.05M |
|
$36.27M |
|
$137.29M |
|
$-88.97M |
|
$-1.90M |
|
$-90.87M |
|
$-90.87M |
|
$-90.96M |
|
$-90.96M |
|
$-90.96M |
|
$-90.96M |
|
$-88.97M |
|
$-73.60M |
|
54.24M |
|
54.24M |
|
$-1.68 |
|
$-1.68 |
|
| Balance Sheet Financials | |
$564.53M |
|
$197.83M |
|
$728.93M |
|
$1.29B |
|
$115.67M |
|
-- |
|
$530.37M |
|
$646.04M |
|
$647.43M |
|
$578.67M |
|
$647.43M |
|
54.70M |
|
| Cash Flow Statement Financials | |
$-51.52M |
|
$-198.68M |
|
$-0.21M |
|
$605.74M |
|
$399.58M |
|
$-206.17M |
|
$20.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.88 |
|
-- |
|
-- |
|
-- |
|
-- |
|
75.07% |
|
-184.13% |
|
-184.13% |
|
-- |
|
-188.06% |
|
-188.25% |
|
$-59.14M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
1.78 |
|
50.61 |
|
-14.05% |
|
-15.72% |
|
-7.03% |
|
-14.05% |
|
$11.84 |
|
$-1.09 |
|
$-0.95 |
|